These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 27062457)

  • 1. Effect and safety of paroxetine for vasomotor symptoms: systematic review and meta-analysis.
    Wei D; Chen Y; Wu C; Wu Q; Yao L; Wang Q; Wang XQ; Yang KH
    BJOG; 2016 Oct; 123(11):1735-43. PubMed ID: 27062457
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of Low-Dose Paroxetine for the Treatment of Hot Flushes in Surgical and Physiological Postmenopausal Women: Systematic Review and Meta-Analysis of Randomized Trials.
    Riemma G; Schiattarella A; La Verde M; Zarobbi G; Garzon S; Cucinella G; Calagna G; Labriola D; De Franciscis P
    Medicina (Kaunas); 2019 Aug; 55(9):. PubMed ID: 31480427
    [No Abstract]   [Full Text] [Related]  

  • 3. Black cohosh (Cimicifuga spp.) for menopausal symptoms.
    Leach MJ; Moore V
    Cochrane Database Syst Rev; 2012 Sep; 2012(9):CD007244. PubMed ID: 22972105
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low-dose paroxetine 7.5 mg for menopausal vasomotor symptoms: two randomized controlled trials.
    Simon JA; Portman DJ; Kaunitz AM; Mekonnen H; Kazempour K; Bhaskar S; Lippman J
    Menopause; 2013 Oct; 20(10):1027-35. PubMed ID: 24045678
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low-dose paroxetine (7.5 mg) improves sleep in women with vasomotor symptoms associated with menopause.
    Pinkerton JV; Joffe H; Kazempour K; Mekonnen H; Bhaskar S; Lippman J
    Menopause; 2015 Jan; 22(1):50-8. PubMed ID: 25137243
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bioidentical hormones for women with vasomotor symptoms.
    Gaudard AM; Silva de Souza S; Puga ME; Marjoribanks J; da Silva EM; Torloni MR
    Cochrane Database Syst Rev; 2016 Aug; 2016(8):CD010407. PubMed ID: 27479272
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Paroxetine: a first for selective serotonin reuptake inhibitors - a new use: approved for vasomotor symptoms in postmenopausal women.
    Weber L; Thacker HL
    Womens Health (Lond); 2014 Mar; 10(2):147-54. PubMed ID: 24601805
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of fezolinetant for vasomotor symptoms in postmenopausal women: A systematic review and meta-analysis of randomized controlled trials.
    Akhtar SMM; Ali A; Khan MS; Khan V; Fareed A; Saleem SZ; Mumtaz M; Ahsan MN; Iqbal S; Asghar MS
    Int J Gynaecol Obstet; 2024 Sep; 166(3):969-983. PubMed ID: 38563867
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acupuncture for menopausal hot flushes.
    Dodin S; Blanchet C; Marc I; Ernst E; Wu T; Vaillancourt C; Paquette J; Maunsell E
    Cochrane Database Syst Rev; 2013 Jul; 2013(7):CD007410. PubMed ID: 23897589
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pooled Analysis of Six Pharmacologic and Nonpharmacologic Interventions for Vasomotor Symptoms.
    Guthrie KA; LaCroix AZ; Ensrud KE; Joffe H; Newton KM; Reed SD; Caan B; Carpenter JS; Cohen LS; Freeman EW; Larson JC; Manson JE; Rexrode K; Skaar TC; Sternfeld B; Anderson GL
    Obstet Gynecol; 2015 Aug; 126(2):413-422. PubMed ID: 26241433
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relaxation for perimenopausal and postmenopausal symptoms.
    Saensak S; Vutyavanich T; Somboonporn W; Srisurapanont M
    Cochrane Database Syst Rev; 2014 Jul; 2014(7):CD008582. PubMed ID: 25039019
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety of gabapentin and pregabalin in patients with vasomotor symptoms: a systematic review and meta-analysis.
    Shan D; Zou L; Liu X; Shen Y; Cai Y; Zhang J
    Am J Obstet Gynecol; 2020 Jun; 222(6):564-579.e12. PubMed ID: 31870736
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacological interventions for the treatment of depression in chronic obstructive pulmonary disease.
    Pollok J; van Agteren JE; Carson-Chahhoud KV
    Cochrane Database Syst Rev; 2018 Dec; 12(12):CD012346. PubMed ID: 30566235
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Paroxetine controlled release in the treatment of menopausal hot flashes: a randomized controlled trial.
    Stearns V; Beebe KL; Iyengar M; Dube E
    JAMA; 2003 Jun; 289(21):2827-34. PubMed ID: 12783913
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Short and long term effects of tibolone in postmenopausal women.
    Formoso G; Perrone E; Maltoni S; Balduzzi S; D'Amico R; Bassi C; Basevi V; Marata AM; Magrini N; Maestri E
    Cochrane Database Syst Rev; 2012 Feb; (2):CD008536. PubMed ID: 22336846
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effectiveness and safety of fezolinetant in alleviating vasomotor symptoms linked to Menopause.: A systematic review and Meta-Analysis.
    Elnaga AAA; Alsaied MA; Elettreby AM; Ramadan A
    Eur J Obstet Gynecol Reprod Biol; 2024 Jun; 297():142-152. PubMed ID: 38640780
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of low-dose paroxetine 7.5 mg on weight and sexual function during treatment of vasomotor symptoms associated with menopause.
    Portman DJ; Kaunitz AM; Kazempour K; Mekonnen H; Bhaskar S; Lippman J
    Menopause; 2014 Oct; 21(10):1082-90. PubMed ID: 24552977
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessing risks and benefits of nonhormonal treatments for vasomotor symptoms in perimenopausal and postmenopausal women.
    Thacker HL
    J Womens Health (Larchmt); 2011 Jul; 20(7):1007-16. PubMed ID: 21675874
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Paroxetine versus placebo for women in midlife after hormone therapy discontinuation.
    Soares CN; Joffe H; Viguera AC; Petrillo L; Rydzewski M; Yehezkel R; Somley B; Cohen LS
    Am J Med; 2008 Feb; 121(2):159-162.e1. PubMed ID: 18261506
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fezolinetant for the treatment of vasomotor symptoms associated with menopause: a meta-analysis.
    Chavez MP; Pasqualotto E; Ferreira ROM; Hohl A; de Moraes FCA; Schmidt PHS; Rodrigues ALSO; de Sa JR
    Climacteric; 2024 Jun; 27(3):245-254. PubMed ID: 38619017
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.